Site icon OncologyTube

ADD-How does minimal residual disease (MRD) testing affect treatment decisions?

In this video, Dr. Brian G.M. Durie explains why MRD-negative status and MRD-positive status are not clear indicators for next steps in a myeloma patients treatment.

The BOTTOM LINE:
MRD-testing is not yet recommended for routine testing, yet the results can be reassuring to patients.

Exit mobile version